Department of Hematology-Oncology, Cooper University Hospital, Camden, New Jersey 08103, USA.
Urology. 2012 May;79(5):e77. doi: 10.1016/j.urology.2011.09.012. Epub 2011 Nov 23.
A 79-year-old man presented with a history of clear cell carcinoma of the right kidney, Fuhrman grade 2, 12 years after nephrectomy, and a history of low-risk prostate adenocarcinoma 11 years after brachytherapy. One year before presentation, the renal cell carcinoma had metastasized to his axial skeleton, and temsirolimus was started. Approximately 1 year later, he presented with a new, painful, lytic lesion in a rare site, his middle phalanx, which was biopsy proven to be clear cell carcinoma.
一位 79 岁男性，12 年前因右肾透明细胞癌（Fuhrman 分级 2 级）行肾切除术，11 年前因前列腺低危腺癌行近距离放射治疗。1 年前，肾细胞癌转移至其轴性骨骼，开始使用替西罗莫司治疗。大约 1 年后，他出现新的、疼痛的、溶骨性病变，位于罕见部位——中指骨，活检证实为透明细胞癌。
